Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Interest Coverage Ratio of 29.52 for Q1 2026, down 25450.14% year-over-year from N/an in Q1 2025, and down 2514.34% quarter-over-quarter from 1.22 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 29.52 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 25450.14% year-over-year to 29.52; the TTM figure through Mar 2026 stood at 29.78 (down 5027.61% YoY), while the FY2025 annual figure was 0.05, up 87.73% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 29.52, down from 1.22 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 3.11 in Q4 2023, with the low at 29.52 in Q1 2026.
- The 5-year median for Interest Coverage Ratio is 0.72 (2023), against an average of 3.02.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio soared 139.92% in 2023, then plunged 25450.14% in 2026.
- Mirum Pharmaceuticals' Interest Coverage Ratio stood at 7.8 in 2022, then jumped by 139.92% to 3.11 in 2023, then tumbled by 222.97% to 3.83 in 2024, then surged by 131.93% to 1.22 in 2025, then tumbled by 2514.34% to 29.52 in 2026.
- Business Quant data shows MIRM's Interest Coverage Ratio at 29.52 in Q1 2026, 1.22 in Q4 2025, and 0.02 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.84 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 24.64 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -0.19 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.18 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.01 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.61 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.08 |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -0.06 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | -29.52 |
| Dec 31, 2025 | 1.22 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | -0.02 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | -3.83 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -1.03 |
| Mar 31, 2024 | -0.18 |
| Dec 31, 2023 | 3.11 |
| Sep 30, 2023 | -0.15 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -7.80 |
| Sep 30, 2022 | -7.89 |
| Jun 30, 2022 | -1.15 |
| Mar 31, 2022 | -2.42 |
| Dec 31, 2021 | 3.52 |
| Sep 30, 2021 | -7.51 |